Dr Ranjeet Singh Medical Research Trust Fund
The late Dr Ranjeet Bhagwan Singh was a prominent medical research scientist. He was the 18th Director of the Institute for Medical Research (IMR) and made many invaluable contributions to the field of medical and scientific research and to the development of diagnostic laboratories in Malaysia. He was also well known for his many philanthropic activities and contributions to mankind. His funds were primarily established to promote the education of the poor and needy, irrespective of race, colour and religion. The late Dr Ranjeet Bhagwan Singh bequeathed his entire estate to the Dr Ranjeet Bhagwan Singh Medical Research Endowment Fund.
The Ministry of Science, Technology and Innovation (MOSTI) is the custodian of the Dr Ranjeet Bhagwan Singh (RBS) Medical Research Trust Fund. This trust fund promotes medical and bio-medical research in Malaysia. The Academy of Sciences Malaysia (ASM) is entrusted by MOSTI to implement these programmes and currently there are two programmes under this trust fund managed by ASM:
- RBS Research Grant
RBS Research Grant is an annual programme under the RBS Medical Research Trust Fund to be awarded to one (1) young Malaysian scientist to undertake medical/ biomedical research.
- RBS Research Workshop Grant
RBS Research Workshop Grant is a biennial programme under the RBS Medical Research Trust Fund. A workshop grant will be awarded to one (1) Malaysian scientist/ institution to conduct a workshop to introduce new research techniques or enhance research technologies in medical or biomedical fields.
Recipient of the 2014 RBS Research Grant
Dr Oon Chern Ein
Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia (USM)
A novel inhibitor of Sirtuin 1 and Sirtuin 2: Elucidation of molecular pathway and therapeutic potential in colorectal cancer (January 2015 - December 2016)
Recipient of the 2015 RBS Research Grant
Dr Dharmani Devi a/p Murugan
Department of Pharmacology, Faculty of Medicine, Universiti Malaya (UM)
Mechanism of actions of the direct vasorelaxant actions of des-Aspartate-angiotensin I (DAA-I), a potential antihypertensive peptide
For further information, please contact:
Mr Nazmi Lao
Scientific Grants Officer
20th Floor, Menara MATRADE
Jalan Sultan Haji Ahmad Shah
50480 Kuala Lumpur
03 - 6203 0633
Closing date 30 October 2016 (Sunday, 12.00 pm)